BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37612465)

  • 1. Impact of pre-transplantation depression and anxiety on the outcome of allogeneic hematopoietic stem cell transplantation: a study from the Transplant Complications Working Party of the EBMT.
    Gjærde LK; Peczynski C; Polge E; Kröger N; de Latour RP; Finke J; Holler E; Blaise D; Helbig G; Salmenniemi U; Potter V; Bunjes D; Erzsebet L; Penack O; Schoemans H; Koenecke C; Basak GW; Perić Z
    Bone Marrow Transplant; 2023 Nov; 58(11):1279-1281. PubMed ID: 37612465
    [No Abstract]   [Full Text] [Related]  

  • 2. Current Practice in Vitamin D Management in Allogeneic Hematopoietic Stem Cell Transplantation: A Survey by the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation.
    Ros-Soto J; Snowden JA; Salooja N; Gilleece M; Parker A; Greenfield DM; Anthias C; Alfred A; Harrington A; Peczynski C; Peggs K; Madrigal A; Basak GW; Schoemans H;
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):2079-2085. PubMed ID: 31229642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of pretransplant inflammatory bowel disease on the outcome of allogeneic hematopoietic stem cell transplantation: a matched-pair analysis study from the Transplant Complications Working Party (TCWP) of the EBMT.
    Peric Z; Peczynski C; Polge E; Kröger N; Sengeloev H; Radujkovic A; Helbig G; Russell N; Bunjes D; Socié G; Potter V; Beelen D; Crawley C; Bloor A; Finke J; Schoemans H; Penack O; Snowden JA; Koenecke C; Basak GW
    Bone Marrow Transplant; 2021 Dec; 56(12):3084-3087. PubMed ID: 34561559
    [No Abstract]   [Full Text] [Related]  

  • 4. Early liver complications after allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of the EBMT.
    Robin M; Gras L; Koster L; Gagelmann N; van Gorkom G; Ederr M; Itälä-Remes M; Zuckerman T; Beguin Y; Schaap N; Drozd-Sokolowska J; Raj K; Hayden PJ; de Wreede LC; Battipaglia G; Polverelli N; Czerw T; Hernandez Boluda JC; Kröger N; Yakoub-Agha I; McLornan DP
    Br J Haematol; 2024 Feb; 204(2):715-718. PubMed ID: 38014808
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcome of allogeneic haematopoietic cell transplantation in eosinophilic disorders: A retrospective study by the chronic malignancies working party of the EBMT.
    McLornan DP; Gras L; Martin I; Sirait T; Schroeder T; Blau IW; Kuball J; Byrne J; Collin M; Stadler M; Desmier D; Salmenniemi U; Jindra P; Mikhailova N; Lenhoff S; Rifón J; Robin M; Rovira M; Veelken H; Sadowska-Klasa A; Zecca M; Hayden PJ; Czerw T; Hernández-Boluda JC; Yakoub-Agha I
    Br J Haematol; 2022 Jul; 198(1):209-213. PubMed ID: 35482558
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of Risk Scoring Systems in HLA-Matched Related Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study.
    Aladağ E; Demiroğlu H; Büyükaşık Y; Göker H
    Turk J Haematol; 2021 Jun; 38(2):138-144. PubMed ID: 32539316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of busulfan in conditioning for allogeneic hematopoietic stem cell transplantation in adults: a survey by the Transplant Complications Working Party of the EBMT.
    Ruutu T; van der Werf S; van Biezen A; Backman JT; Peczynski C; Kröger N; Mohty M; Nagler A; Montoto S; Langebrake C; Niederwieser D; Peric Z; Koenecke C; Duarte RF; Basak G
    Bone Marrow Transplant; 2019 Dec; 54(12):2013-2019. PubMed ID: 31160806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treosulfan conditioning for allogeneic transplantation in multiple myeloma - improved overall survival in first line haematopoietic stem cell transplantation - a large retrospective study by the Chronic Malignancies Working Party of the EBMT.
    Gran C; Wang J; Nahi H; Koster L; Gahrton G; Einsele H; Niittyvoupio R; Edinger M; Beelen D; Ciceri F; Bornhäuser M; Finke J; de Wreede LC; Ljungman P; Mielke S; Tischer J; Garderet L; Schönland S; Yakoub-Agha I; Kröger N
    Br J Haematol; 2020 Jun; 189(5):e213-e217. PubMed ID: 32301111
    [No Abstract]   [Full Text] [Related]  

  • 9. Variability of nutritional practices in peritransplant period after allogeneic hematopoietic stem cell transplantation: a survey by the Complications and Quality of Life Working Party of the EBMT.
    Peric Z; Botti S; Stringer J; Krawczyk J; van der Werf S; van Biezen A; Aljurf M; Murray J; Liptrott S; Greenfield DM; Duarte RF; Ruutu T; Basak GW
    Bone Marrow Transplant; 2018 Aug; 53(8):1030-1037. PubMed ID: 29515252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced intensity conditioning allogeneic hematopoietic cell transplantation for adult acute myeloid leukemia in complete remission - a review from the Acute Leukemia Working Party of the EBMT.
    Sengsayadeth S; Savani BN; Blaise D; Malard F; Nagler A; Mohty M
    Haematologica; 2015 Jul; 100(7):859-69. PubMed ID: 26130513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome unclassifiable - a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
    Drozd-Sokolowska J; Gras L; Zinger N; Zahrani MA; Passweg J; Byrne J; Ho A; Huang XJ; Kröger N; Mayer J; Russo D; De Becker A; Tbakhi A; Stamatoullas A; Valerius T; Hayden P; McLornan DP; Onida F; Scheid C; Robin M; Yakoub-Agha I
    Bone Marrow Transplant; 2023 Feb; 58(2):222-225. PubMed ID: 36402922
    [No Abstract]   [Full Text] [Related]  

  • 12. Validation of the European Group for Blood and Marrow Transplantation (EBMT) risk score in patients receiving allogeneic hematopoietic stem cell transplantation at a single center in Japan.
    Numata A; Tanaka M; Matsumoto K; Takasaki H; Tachibana T; Fujimaki K; Sakai R; Fujisawa S; Tomita N; Fujita H; Maruta A; Ishigatsubo Y; Kanamori H
    Clin Transplant; 2014 Apr; 28(4):403-9. PubMed ID: 24655161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
    El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
    Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR.
    Sureda A; Zhang MJ; Dreger P; Carreras J; Fenske T; Finel H; Schouten H; Montoto S; Robinson S; Smith SM; Boumedil A; Hamadani M; Pasquini MC
    Cancer; 2018 Apr; 124(8):1733-1742. PubMed ID: 29424927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT.
    Pavlů J; Labopin M; Niittyvuopio R; Socié G; Yakoub-Agha I; Wu D; Remenyi P; Passweg J; Beelen DW; Aljurf M; Kröger N; Labussière-Wallet H; Perić Z; Giebel S; Nagler A; Mohty M
    J Hematol Oncol; 2019 Oct; 12(1):108. PubMed ID: 31647022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of patients receiving haematopoietic allogeneic stem cell transplantation as first transplant for high-risk Hodgkin lymphoma: a retrospective analysis from the Lymphoma Working Party-EBMT.
    Gutiérrez-García G; Martínez C; Boumendil A; Finel H; Malladi R; Afanasyev B; Tsoulkani A; Wilson KMO; Bloor A; Nikoloudis M; Richardson D; López-Corral L; Castagna L; Cornelissen J; Giltat A; Collin M; Fanin R; Bonifazi F; Robinson S; Montoto S; Peggs KS; Sureda A
    Br J Haematol; 2022 Feb; 196(4):1018-1030. PubMed ID: 34750806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed phenotype acute leukemia: outcomes with allogeneic stem cell transplantation. A retrospective study from the Acute Leukemia Working Party of the EBMT.
    Munker R; Labopin M; Esteve J; Schmid C; Mohty M; Nagler A
    Haematologica; 2017 Dec; 102(12):2134-2140. PubMed ID: 28971902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
    Passweg JR; Labopin M; Christopeit M; Cornelissen J; Pabst T; Socié G; Russel N; Yakoub-Agha I; Blaise D; Gedde-Dahl T; Labussière-Wallet H; Malladi R; Forcade E; Maury S; Polge E; Lanza F; Gorin NC; Mohty M; Nagler A
    Biol Blood Marrow Transplant; 2020 Apr; 26(4):659-664. PubMed ID: 31759159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic hematopoietic stem cell transplantation for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 B-cell precursor acute lymphoblastic leukemia in first complete remission: impact of pretransplant measurable residual disease (MRD) status. An analysis from the Acute Leukemia Working Party of the EBMT.
    Esteve J; Giebel S; Labopin M; Czerw T; Wu D; Volin L; Socié G; Yakoub-Agha I; Maertens J; Cornelissen JJ; Pigneux A; Shimoni A; Schwerdtfeger R; Labussière-Wallet H; Russell N; Schattenberg A; Chevallier P; Koza V; Foà R; Schmid C; Peric Z; Mohty M; Nagler A
    Leukemia; 2021 Aug; 35(8):2232-2242. PubMed ID: 33542481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT.
    Heidenreich S; Ziagkos D; de Wreede LC; van Biezen A; Finke J; Platzbecker U; Niederwieser D; Einsele H; Bethge W; Schleuning M; Beelen DW; Tischer J; Nagler A; Glass B; Maertens J; Yáñez L; Beguin Y; Sill H; Scheid C; Stelljes M; Ganser A; Zachée P; Selleslag D; de Witte T; Robin M; Kröger N
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):44-52. PubMed ID: 27720995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.